Special Drug Use Investigation of Zevalin.

Trial Profile

Special Drug Use Investigation of Zevalin.

Phase of Trial: Phase IV

Latest Information Update: 28 Nov 2011

At a glance

  • Drugs Ibritumomab tiuxetan; Ibritumomab tiuxetan
  • Indications Non-Hodgkin's lymphoma
  • Focus Therapeutic Use
  • Acronyms ZEVALIN-SDUI
  • Sponsors Bayer
  • Most Recent Events

    • 28 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top